- Report
- May 2024
- 138 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Cabergoline is a drug used to treat a variety of conditions related to the central nervous system. It is primarily used to treat hyperprolactinemia, a condition in which the body produces too much of the hormone prolactin. It is also used to treat Parkinson's disease, as well as other neurological disorders such as restless leg syndrome and fibromyalgia. Cabergoline is a dopamine agonist, meaning it works by stimulating dopamine receptors in the brain.
Cabergoline is available in both oral and injectable forms, and is typically prescribed in combination with other medications. It is generally well-tolerated, with few side effects. Common side effects include nausea, headache, and dizziness.
The cabergoline market is a small but growing segment of the central nervous system drugs market. It is used to treat a variety of conditions, and is generally well-tolerated with few side effects.
Some companies in the cabergoline market include Sun Pharmaceuticals, Lupin Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more